GoNitro
- Generic Name: nitroglycerine sublingual powder
- Brand Name: GoNitro
GoNitro (Nitroglycerine Sublingual Powder) side effects drug center
GoNitro Side Effects Center
GoNitro (nitroglycerin) Packets is a nitrate vasodilator indicated for acute relief of an attack or prophylaxis of angina pectoris due to coronary artery disease. Common side effects of GoNitro include:
- headache
- dizziness
- numbness and tingling
- weakness
- drowsiness
- flushing
- drug rash
- skin redness and scaling
- nausea
- vomiting
- temporary low blood oxygen levels
- fast heart rate
The recommended dose of GoNitro Packets is one or two packets (400 mcg of nitroglycerin per packet) at the onset of an attack under the tongue. One additional GoNitro Packet may be administered every five minutes as needed. GoNitro may interact with antihypertensives, ergotamine, PDE-5-inhibitors, guanylate cyclase (sGC) stimulators. Tell your doctor all medications and supplements you use. Tell your doctor if you are pregnant or plan to become pregnant before using GoNitro; it is unknown if it would harm a fetus. It is unknown if GoNitro passes into breast milk. Consult your doctor before breastfeeding.
Our GoNitro (nitroglycerin) Packets Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
GoNitro Professional Information
SIDE EFFECTS
Clinical Trials Experience
Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in clinical practice.
Adverse reactions occurring at a frequency greater than 2% and greater than placebo included: headache, dizziness, and paresthesia.
Postmarketing Experience
The following adverse reactions have been identified during post-approval use of GONITRO and other nitroglycerin drugs. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to estimate their frequency reliably or establish a causal relationship to drug exposure.
Neurologic: weakness, drowsiness
Dermatologic: cutaneous vasodilation, flushing, drug rash, exfoliative dermatitits
Gastrointestinal: nausea, vomiting
Respiratory: transient hypoxemia
Cardiovascular: tachycardia
Read the entire FDA prescribing information for GoNitro (Nitroglycerine Sublingual Powder)
&Copy; GoNitro Patient Information is supplied by Cerner Multum, Inc. and GoNitro Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.